DEVICE FOR STAINING 3D BIOPSY TISSUE
20210270705 · 2021-09-02
Inventors
- Pieter Jan van der Zaag (Waalre, NL)
- Roland Cornelis Martinus Vulders (Eindhoven, NL)
- DANIELLE ELISA WILLEMINE CLOUT (EINDHOVEN, NL)
- JOHANNES THEODORUS WILHELMUS MARIA VAN EEMEREN (HELMOND, NL)
- Anja VAN DE STOLPE (Vught, NL)
Cpc classification
A61B10/0275
HUMAN NECESSITIES
G01N1/30
PHYSICS
A61B10/04
HUMAN NECESSITIES
A61B10/0283
HUMAN NECESSITIES
International classification
A61B10/00
HUMAN NECESSITIES
A61B10/02
HUMAN NECESSITIES
Abstract
A method and system for processing a 3D tissue sample is provided, comprising the steps of receiving a tube with an inner space and two open ends, wherein the tube is configured to retain the 3D tissue sample in the inner space, arranging the tube so that one of the two open ends of the tube is located at a fluid channel, and forcing or actively pressing a tissue processing agent through the fluid channel and into the tube so that the tissue processing agent passes through the tissue.
Claims
1. A method of processing an intact 3D tissue sample, comprising the steps of receiving a tube with an inner space and at least two open ends, wherein the tube is configured to retain the 3D tissue sample in the inner space, arranging the tube so that one of the two open ends of the tube is located at a fluid channel, forcing a tissue processing agent through the fluid channel and into the tube so that the tissue processing agent passes through the tissue, while the tissue is retained in the tube.
2. The method of claim 1, wherein the pressure under which the tissue processing fluid is supplied is higher than atmospheric pressure.
3. The method of claim 1, wherein the tissue processing agent is forced through the fluid channel and into the tube over a predetermined time, preferably over at least 10 minutes.
4. The method of claim 1, wherein the tissue processing agent is an agent out of the group consisting of a clearing agent and a staining agent.
5. The method of claim 1, further comprising the step of analyzing the tissue retained in the tube, after the tissue processing agent has passed through the tissue.
6. The method of claim 1, further comprising the step of 3D imaging the tissue retained in the tube.
7. A system for processing an intact 3D tissue sample, comprising: a tube, the tube having a first open end, a second open end and an inner space for accommodating the 3D tissue sample, a tube retainer, and a pumping device for supplying a tissue processing fluid under pressure into the tube, wherein, when the tube is retained by the tube retainer, one of the first and second open ends of the tube is arranged so that the tissue processing fluid is suppliable into the tube so that the tissue processing agent is forced through the 3D tissue sample, while the 3D tissue sample is accommodated and retained in the tube.
8. The system of claim 7, wherein the pressure under which the tissue processing fluid is supplied is higher than atmospheric pressure.
9. The system of claim 7, wherein the pressure under which the tissue processing fluid is supplied is between 2 bar and 6 bar, preferably between 4 bar and 5 bar.
10. The system of claim 7, wherein the pumping device for supplying the tissue processing fluid is configured for supplying the tissue processing fluid with a constant pressure over a predetermined time, preferably over at least 10 minutes.
11. The system of claim 7, further comprising a fluid channel between the pumping device and the tube.
12. The system of claim 7, wherein the tube is made of a transparent material.
13. The system of claim 12, further comprising an optical analyzing unit MK-h for analyzing tissue accommodated in the tube.
14. The system of claim 7, wherein the tube has a length between 5 mm and 20 mm.
15. The system of claim 7, wherein the tube has an outer diameter of up to 2 mm, preferably up to 1 mm.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059] The illustration in the drawings is schematically only and not to scale. It is noted that similar elements are provided with the same reference signs in different figures, if appropriate.
DETAILED DESCRIPTION OF EMBODIMENTS
[0060] In
[0061] The tube shaft 30, as shown in
[0062] The biopsy device as shown in
[0063] For example, the biopsy tube 20 may be inserted with an inclined orientation and with the proximal end 22 first. This may have the advantage that an attachment of the biopsy tube to the distal end of the tube shaft may be better controlled by hand. The kind of movement of this example is indicated by the bolt arrow in
[0064] Alternatively, the biopsy tube 20 may be inserted into the notch 16 of the main shaft 10 with a parallel orientation of the longitudinal axis of the biopsy tube and the longitudinal axis of the main shaft. In this case, the tube shaft 30 may be pulled a few millimetres backwards, i.e. proximally, to give the biopsy tube enough space to be inserted into the notch. Subsequently, the tube shaft 30 may be pushed forwards, i.e. distally, so that the portion 33 with the reduced diameter may engage the biopsy tube so as to attach the biopsy tube to the tube shaft.
[0065]
[0066]
[0067] The liquid or fluid in the reservoir 85 may be suitable for treating the tissue in the tube. For example, the liquid or fluid may be suitable for clearing the cellular structures of the tissue. Otherwise, the fluid or liquid may be for staining the tissue. When activated, the pumping device 84 will suck at its entering side the liquid or fluid from the reservoir 85 through the fluid channel 87, and will supply the liquid or fluid under pressure through the fluid channel 83 on its exit side.
[0068] A seal 86 may be located in the tube retainer 82 so as to seal a fluid path from the fluid channel 83 into the end of the tube 20.
[0069] Although it is shown in
[0070]
[0071] A radiation source 94 is arranged relative to the tube 20 and is configured so as to apply a radiation, for example light with a predetermined frequency to the tube 20. The radiation passing through the tube and the tissue within the same may be detected by a radiation detector 98 so as to provide images or at least data allowing further investigation or analyzing of the tissue. An improved detection of the radiation may be achieved by providing a lens 96 within the light path between the tube 20 and the radiation detector 98.
[0072]
[0073] An optical fiber 42 may be provided for illuminating and collecting light, with a distal end of the optical fiber at the tip, i.e. at the end surface 44 of the fiber body. The proximal end of the fiber may be connected to an optical console capable of emitting and receiving light. For optimal tissue sensing, it may be advantageous to guide at least two optical fibers 44 (source and detector) towards the tip, with the fiber tip ends having a maximized distance from each other.
[0074] As a further feature, an opening for applying vacuum can be realized within the main shaft, the tube shaft and/or in the fiber body, and it may be used for sucking tissue into the notch 16 after the main shaft 10 has been ejected to ensure that the biopsy is of sufficient size. By way of this, the vacuum may also ensure that the tissue is brought in close contact with the optical fibers 44 facing the proximal side of the exposed notch 16, for the case that the tissue in the notch is characterized prior to obtaining the biopsy.
[0075] The incorporation of a small opening for applying vacuum can also allow for simultaneous biological/physiological analysis of the blood/tissue under consideration, thus obtaining a better biopsy quality. The vacuum can be used to suck in small amounts (microliter) of body fluid (for instance blood/serum, bile, or else) for instant biochemical analysis, which can be used to complement the optical tissue characterization.
[0076] For this, the vacuum is preferably realized by a small vacuum opening within or at the fiber body, so that the blood sampling can be performed within the described design at the tip and also in the notch. The absorbed blood/cells could be analyzed by appropriate detectors (such as chip-sized microfluidic devices and/or MEMS) connected to the distal end of the vacuum channel, thereby enabling instantaneous analysis.
[0077] For instance, MEMS-based pH sensors could allow for complementary classification of tumor (acidic) vs. normal (basic) tissue based on pH. Apart from pH sensors, also other specific sensors may be used that could characterize the tissue sample in consideration. This could serve as complimentary means to support the optical tissue sensing in difficult cases, and thereby improve the results of photonic biopsy procedures even further.
[0078] The optical fibers and the vacuum channel may be integrated into the shaft and/or fiber body in a way to ensure (1) a sufficiently large fiber distance for tissue characterization, and that (2) the opening has an appropriate size for sucking the tissue samples into the biopsy tube without hampering the stability of the shaft and/or fiber body.
[0079] Through
[0080] As shown in
[0081] Optionally it is also possible that the console is coupled to an imaging modality capable of imaging the interior of the body, for instance when the biopsy is taken under image guidance. In this case it is also possible to store the image of the interior when the biopsy is taken to a container of the biopsy. In this case the in-vivo information of the optical biopsy needle, the information of the pathology of the biopsy as well as the location where the biopsy was taken may be brought together for advanced pathology.
[0082] On the other hand, also other optical methods can be envisioned like diffuse optical tomography by employing a plurality of optical fibers, differential path length spectroscopy, fluorescence and Raman spectroscopy to extract tissue properties.
[0083] Further shown in
[0084] The device 62 may be connected on the one hand to the console 60 and on the other hand to the device 80 by means of wires or wireless, for interchanging information like control commands or data representing pathological aspects of an inspected tissue sample.
[0085] It is to be noted, that the device 80 in
[0086] The device 62 may be a digital pathology system consisting of an optical scanner and an image management system to enable digitizing, storage, retrieval, and processing of tissue staining images, reading the information stored in the storage box container, and integrating this information with the digitized staining data set, to be presented to the pathologist. In addition to this, the data set from the photonic biopsy device may be either presented next to the histopathology image or the two data sets may be fused in the image, characterized and recognizable by a certain coloring pattern of the image. For instance the oxygenation level measured in-vivo could be added as a red color, where deep red means low oxygenation and bright red would mean high oxygenation level. Additionally, molecular spatial distributions from FTIR or Raman could be added as a color coded mapping to the pathology slide of specific molecules.
[0087] It may be summarized that the tissue sample, which may firstly be subjected to an in-vivo tissue inspection, i.e. an inspection within a living body, may secondly subjected to an ex-vivo tissue inspection by means of the devices 80 and 62.
[0088] A processor transforms the measured spectrum into physiological parameters that are indicative for the tissue state and a monitor 68 may be used to visualize the results.
[0089] A computer program executable on the processor may be provided on a suitable medium such as an optical storage medium or a solid-state medium supplied together with or as part of the processor, but may also be distributed in other forms, such as via the Internet or other wired or wireless telecommunication systems.
[0090] For fluorescence measurements the console must be capable of providing excitation light to at least one source fiber while detecting tissue-generated fluorescence through one or more detection fibers. The excitation light source may be a laser (e.g. a semiconductor laser), a light-emitting diode (LED) or a filtered light source, such as a filtered mercury lamp. In general, the wavelengths emitted by the excitation light source are shorter than the range of wavelengths of the fluorescence that is to be detected. It is preferable to filter out the excitation light using a detection filter in order to avoid possible overload of the detector by the excitation light. A wavelength-selective detector, e.g. a spectrometer, is required when multiple fluorescent entities are present that need to be distinguished from each other.
[0091] In case fluorescence measurements are to be combined with diffuse reflectance measurements, the excitation light for measuring fluorescence may be provided to the same source fiber as the light for diffuse reflectance. This may be accomplished by, e.g., using a fiber switch, or a beam splitter or dichroic beam combiner with focusing optics. Alternatively, separate fibers may be used for providing fluorescence excitation light and light for diffuse reflectance measurements.
[0092] The described devices can be used in minimally invasive needle interventions such as low-back pain interventions or taking biopsies in the field of cancer diagnosis or in case where tissue characterization around the needle is required.
[0093] While the invention has been illustrated and described in detail in the drawings and foregoing description, such illustration and description are to be considered illustrative or exemplary and not restrictive; the invention is not limited to the disclosed embodiments. Other variations to the disclosed embodiments may be understood and effected by those skilled in the art in practicing the claimed invention, from a study of the drawings, the disclosure, and the appended claims.
[0094] In the claims, the word “comprising” does not exclude other elements or steps, and the indefinite article “a” or “an” does not exclude a plurality. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measured cannot be used to advantage. Any reference signs in the claims should not be construed as limiting the scope.
LIST OF REFERENCE SIGNS
[0095] 10 main shaft [0096] 12 channel of main shaft [0097] 14 distal tip [0098] 16 notch [0099] 18 recess [0100] 20 biopsy tube [0101] 22 proximal end [0102] 24 distal end [0103] 26 longitudinal axis [0104] 28 channel of biopsy tube [0105] 30 tube shaft [0106] 32 first end [0107] 33 end portion [0108] 34 second end [0109] 36 longitudinal axis [0110] 38 channel of tube shaft [0111] 42 optical fiber [0112] 44 end surface of fiber body [0113] 50 outer sleeve [0114] 52 cutting edge [0115] 54 lateral opening [0116] 56 inwardly protruding edge [0117] 60 console [0118] 62 device for ex-vivo tissue inspection [0119] 64 light source [0120] 66 light detector [0121] 68 monitor [0122] 70 suction device [0123] 80 tissue processing device [0124] 82 tube retainer [0125] 83, 87 fluid channel [0126] 84 pumping device [0127] 85 reservoir [0128] 86 seal [0129] 90 tissue inspection device [0130] 92 tube retainer [0131] 94 radiation source [0132] 96 lens [0133] 98 radiation detector [0134] 100 shaft [0135] 200 notch [0136] 220 inner region of tissue sample [0137] 240 outer region of tissue sample [0138] 260 tissue sample [0139] 300 open receptacle [0140] 400 staining fluid [0141] 500 outer member